Canan Kasikara

发表

Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6

R. Birge, V. Kholodovych, S. Kotenko, 2017, Front. Immunol..

The role of non‐resolving inflammation in atherosclerosis

I. Tabas, Amanda C. Doran, C. Kasikara, 2018, The Journal of clinical investigation.

Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression

R. Birge, S. Kotenko, A. Krantz, 2017, Molecular Cancer Research.

Contribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity

R. Birge, Yi Wu, Sushil Kumar, 2014, Front. Immunol..

Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis.

R. Schwabe, R. Birge, R. Chung, 2019, Cell metabolism.

Iterative Tyrosine Phosphorylation Controls Non-canonical Domain Utilization in Crk

P. Hornbeck, R. Birge, C. Kalodimos, 2014, Oncogene.

Cyclophilin A Inhibitor Debio-025 Targets Crk, Reduces Metastasis, and Induces Tumor Immunogenicity in Breast Cancer

R. Birge, C. Kalodimos, E. Azzam, 2020, Molecular Cancer Research.

Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase

R. Birge, A. Lewis-Antes, S. Kotenko, 2016, Cell Communication and Signaling.

MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity

R. Birge, R. Ramakrishnan, I. Tabas, 2018, Science Signaling.

TAM receptors and their ligand-mediated activation: Role in atherosclerosis.

C. Kasikara, Bishuang Cai, Canan Kasikara, 2020, International review of cell and molecular biology.

Efferocytosis induces macrophage proliferation to help resolve tissue injury.

Na Kong, I. Tabas, Arif Yurdagul, 2021, Cell metabolism.

Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity

R. Birge, S. Kotenko, Yun-juan Chang, 2020, Cancer Research.

Deficiency of macrophage PHACTR1 impairs efferocytosis and promotes atherosclerotic plaque necrosis.

M. Reilly, D. Saleheen, G. Fredman, 2021, The Journal of clinical investigation.

Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis

B. Hubbard, I. Tabas, Arif Yurdagul, 2021, bioRxiv.

Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer.

M. Yaffe, R. Birge, S. Kotenko, 2019, Cancer research.